David Toung
Stock Analyst at Argus Research
(3.34)
# 1,020
Out of 5,042 analysts
127
Total ratings
64.29%
Success rate
10.12%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Buy | $80 → $90 | $73.99 | +21.64% | 2 | Sep 19, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $93.67 | +22.77% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $290.65 | -2.98% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $342.35 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $35.32 | +47.23% | 1 | Jul 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $572.50 | -17.90% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $362.50 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $16.11 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $227.99 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $161.89 | -22.79% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $197.04 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $291.76 | +16.53% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $801.67 | -16.42% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $103.03 | +45.59% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $825.45 | +1.76% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $78.14 | +40.77% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $279.49 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.76 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $381.79 | -18.80% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $447.04 | -30.65% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $546.51 | -41.45% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $126.85 | +6.42% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $120.94 | -37.99% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $43.83 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $87.49 | +25.73% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.46 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $65.91 | +85.87% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $83.29 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $130.36 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $190.40 | -18.59% | 4 | Mar 27, 2020 |
Hologic
Sep 19, 2025
Maintains: Buy
Price Target: $80 → $90
Current: $73.99
Upside: +21.64%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $93.67
Upside: +22.77%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $290.65
Upside: -2.98%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $342.35
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $35.32
Upside: +47.23%
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $572.50
Upside: -17.90%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $362.50
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $16.11
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $227.99
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $161.89
Upside: -22.79%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $197.04
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $291.76
Upside: +16.53%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $801.67
Upside: -16.42%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $103.03
Upside: +45.59%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $825.45
Upside: +1.76%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $78.14
Upside: +40.77%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $279.49
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $24.76
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $381.79
Upside: -18.80%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $447.04
Upside: -30.65%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $546.51
Upside: -41.45%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $126.85
Upside: +6.42%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $120.94
Upside: -37.99%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $43.83
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $87.49
Upside: +25.73%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $9.46
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $65.91
Upside: +85.87%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $83.29
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $130.36
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $190.40
Upside: -18.59%